RTP4 Suppresses Colorectal Cancer Progression via MHC‐I‐Mediated CD8 + T Cell Infiltration and Enhances Immunotherapy Response
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Chengpeng Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, CD8-Positive T-Lymphocytes, Immunotherapy, Histocompatibility Antigens Class I. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
While RTP4 is known to regulate odorant receptor trafficking, its role in colorectal cancer (CRC) remains unclear. This study investigates the clinical relevance and functional mechanisms of RTP4 in CRC. Comprehensive analyses revealed significant downregulation of RTP4 expression in CRC tissues, correlating with poor patient prognosis. RTP4 expression showed strong associations with immune‐related genes, biological processes and anti‐tumour immune cell infiltration. Mechanistic studies demonstrated that RTP4 upregulates MHC‐I expression, which enhances CD8 + T cell recruitment and strengthens anti‐tumour immunity in both cellular and animal models. Furthermore, RTP4 overexpression markedly improved the efficacy of immune checkpoint blockade therapy. All in all, our findings establish RTP4 as a dual‐functional biomarker for prognosis prediction and a potential target to enhance immunotherapy responsiveness in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Clinical College, Nanchang Medical College, Nanchang, China.
- Huan - Kui Academy, Jiangxi Medical College, Nanchang University, Nanchang, China.
- The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital, School of Basic Medical Sciences, Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang, China.
ORCID-Profile: Haifeng Ye
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, C., Li, Y., Liu, Z., Ye, W., Wei, L., Xu, W., Yan, L., & Ye, H. (2025). RTP4 Suppresses Colorectal Cancer Progression via MHC‐I‐Mediated CD8 + T Cell Infiltration and Enhances Immunotherapy Response. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70915
Vancouver
Yu C, Li Y, Liu Z, Ye W, Wei L, Xu W, et al. RTP4 Suppresses Colorectal Cancer Progression via MHC‐I‐Mediated CD8 + T Cell Infiltration and Enhances Immunotherapy Response. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70915
BibTeX
@article{Yu2025,
author = {Yu, Chengpeng and Li, Yifan and Liu, Zhenzhe and Ye, Wen and Wei, Lin and Xu, Weiqi and Yan, Likun and Ye, Haifeng},
title = {RTP4 Suppresses Colorectal Cancer Progression via MHC‐I‐Mediated CD8 + T Cell Infiltration and Enhances Immunotherapy Response},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70915}
}
EUVIMED